换一批
换一批Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
作者：
Nicola S,Meagher [1]
;
Kylie L,Gorringe [2]
;
Matthew,Wakefield [3]
;
Adelyn,Bolithon [1]
;
Chi Nam Ignatius,Pang [4]
;
Derek S,Chiu [5]
;
Michael S,Anglesio [6]
;
Kylie-Ann,Mallitt [7]
;
Jennifer A,Doherty [8]
;
Holly R,Harris [9]
;
Joellen M,Schildkraut [10]
;
Andrew,Berchuck [11]
;
Kara L,Cushing-Haugen [12]
;
Ksenia,Chezar [13]
;
Angela,Chou [14]
;
Adeline,Tan [15]
;
Jennifer,Alsop [16]
;
Ellen,Barlow [17]
;
Matthias W,Beckmann [18]
;
Jessica,Boros [19]
;
David D L,Bowtell [2]
;
AOCS Group [20]
;
Alison H,Brand [21]
;
James D,Brenton [2]
;
Ian,Campbell [2]
;
Dane,Cheasley [22]
;
Joshua,Cohen [23]
;
Cezary,Cybulski [24]
;
Esther,Elishaev [25]
;
Ramona,Erber [26]
;
Rhonda,Farrell [27]
;
Anna,Fischer [28]
;
Zhuxuan,Fu [29]
;
Blake,Gilks [14]
;
Anthony J,Gill [30]
;
Australian Pancreatic Genome Initiative [31]
;
Charlie,Gourley [32]
;
Marcel,Grube [27]
;
Paul R,Harnett [33]
;
Arndt,Hartmann [34]
;
Anusha,Hettiaratchi [35]
;
Claus K,Høgdall [36]
;
Tomasz,Huzarski [37]
;
Anna,Jakubowska [19]
;
Mercedes,Jimenez-Linan [38]
;
Catherine J,Kennedy [39]
;
Byoung-Gie,Kim [40]
;
Jae-Weon,Kim [41]
;
Jae-Hoon,Kim [42]
;
Kayla,Klett [22]
;
Jennifer M,Koziak [43]
;
Tiffany,Lai [22]
;
Angela,Laslavic [44]
;
Jenny,Lester [45]
;
Yee,Leung [46]
;
Na,Li [47]
;
Winston,Liauw [48]
;
Belle W X,Lim [23]
;
Anna,Linder [47]
;
Jan,Lubiński [49]
;
Sakshi,Mahale [45]
;
Constantina,Mateoiu [50]
;
Simone,McInerny [13]
;
Janusz,Menkiszak [31]
;
Parham,Minoo [51]
;
Suzana,Mittelstadt [22]
;
David,Morris [52]
;
Sandra,Orsulic [53]
;
Sang-Yoon,Park [54]
;
Celeste Leigh,Pearce [55]
;
John V,Pearson [33]
;
Malcolm C,Pike [56]
;
Carmel M,Quinn [57]
;
Ganendra Raj,Mohan [11]
;
Jianyu,Rao [18]
;
Marjorie J,Riggan [58]
;
Matthias,Ruebner [59]
;
Stuart,Salfinger [16]
;
Clare L,Scott [60]
;
Mitul,Shah [61]
;
Helen,Steed [47]
;
Colin J R,Stewart [62]
;
Deepak,Subramanian [63]
;
Soseul,Sung [64]
;
Katrina,Tang [65]
;
Paul,Timpson [27]
;
Robyn L,Ward [47]
;
Rebekka,Wiedenhoefer [66]
;
Heather,Thorne [67]
;
kConFab Investigators [18]
;
Paul A,Cohen [23]
;
Philip,Crowe [68]
;
Peter A,Fasching [69]
;
Jacek,Gronwald [70]
;
Nicholas J,Hawkins [45]
;
Estrid,Høgdall [22]
;
David G,Huntsman [71]
;
Paul A,James [31]
;
Beth Y,Karlan [22]
;
Linda E,Kelemen [72]
;
Stefan,Kommoss [73]
;
Gottfried E,Konecny [27]
;
Francesmary,Modugno [48]
;
Sue K,Park [74]
;
Annette,Staebler [75]
;
Karin,Sundfeldt [76]
;
Anna H,Wu [77]
;
Aline,Talhouk [78]
;
Paul D P,Pharoah [13]
;
Lyndal,Anderson [79]
;
Anna,DeFazio [1]
;
Martin,Köbel ;
Michael L,Friedlander ;
Susan J,Ramus
作者单位：
School of Clinical Medicine, Faculty of Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.;Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia.
[1]
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Victoria, Australia.
[2]
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.;Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.;Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Victoria, Australia.
[3]
School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, New South Wales, Australia.;Bioinformatics Unit, Children's Medical Research Institute, Westmead, Sydney, Australia.
[4]
British Columbia's Gynecological Cancer Research Team (OVCARE), University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, British Columbia, Canada.
[5]
British Columbia's Gynecological Cancer Research Team (OVCARE), University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, British Columbia, Canada.;Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
[6]
School of Clinical Medicine, Faculty of Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.;Centre for Big Data Research in Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
[7]
Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah.
[8]
Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.;Department of Epidemiology, University of Washington, Seattle, Washington.
[9]
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
[10]
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina.
[11]
Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.
[12]
Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada.
[13]
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.;Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, New South Wales, Australia.;The University of Sydney, Sydney, New South Wales, Australia.
[14]
Division of Obstetrics and Gynaecology, Medical School, University of Western Australia, Crawley, Western Australia, Australia.;Western Women's Pathology, Western Diagnostic Pathology, Wembley, Western Australia, Australia.
[15]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
[16]
Gynaecological Cancer Centre, Royal Hospital for Women, Sydney, New South Wales, Australia.
[17]
Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
[18]
The University of Sydney, Sydney, New South Wales, Australia.;Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.;Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
[19]
The University of Sydney, Sydney, New South Wales, Australia.;Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
[20]
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
[21]
David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California.
[22]
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
[23]
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
[24]
Institute of Pathology, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander Universität Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany.
[25]
The University of Sydney, Sydney, New South Wales, Australia.;Prince of Wales Private Hospital, Randwick, New South Wales, Australia.
[26]
Institute of Pathology and Neuropathology, Tübingen University Hospital, Tübingen, Germany.
[27]
Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
[28]
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
[29]
Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, United Kingdom.
[30]
Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
[31]
The University of Sydney, Sydney, New South Wales, Australia.;Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.
[32]
The Health Precincts Biobank (formerly the Health Science Alliance Biobank), UNSW Biospecimen Services, Mark Wainwright Analytical Centre, University of New South Wales Sydney, Sydney, New South Wales, Australia.
[33]
Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
[34]
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.;Department of Genetics and Pathology, University of Zielona Góra, Zielona Góra, Poland.
[35]
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.;Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
[36]
Department of Histopathology, Addenbrooke's Hospital, Cambridge, United Kingdom.
[37]
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
[38]
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
[39]
Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
[40]
Women's Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, Pennsylvania.
[41]
Alberta Health Services-Cancer Care, Calgary, Alberta, Canada.
[42]
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
[43]
Division of Obstetrics and Gynaecology, Medical School, University of Western Australia, Crawley, Western Australia, Australia.;Department of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.;Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
[44]
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Parkville Familial Cancer Centre, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[45]
School of Clinical Medicine, Faculty of Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.;Cancer Care Centre, St George Hospital, Sydney, New South Wales, Australia.
[46]
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[47]
Department of Obstetrics and Gynecology, Inst of Clinical Science, Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden.
[48]
Department of Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
[49]
Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland.
[50]
St George and Sutherland Clinical School, University of New South Wales Sydney, Sydney, New South Wales, Australia.
[51]
Center for Gynecologic Cancer, National Cancer Center Institute for Cancer Control, Goyang, Republic of Korea.
[52]
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.;Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.
[53]
QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
[54]
Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.;Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York.
[55]
Department of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.;Department of Gynaecological Oncology, St John of God Subiaco Hospital, Subiaco, Western Australia, Australia.;School of Medicine, University of Notre Dame, Fremantle, Western Australia, Australia.
[56]
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
[57]
Department of Gynaecological Oncology, St John of God Subiaco Hospital, Subiaco, Western Australia, Australia.
[58]
Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Victoria, Australia.;The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.;Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.;Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Victoria, Australia.
[59]
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, Canada.;Section of Gynecologic Oncology Surgery, North Zone, Alberta Health Services, Edmonton, Alberta, Canada.
[60]
School for Women's and Infants' Health, University of Western Australia, Perth, Western Australia, Australia.
[61]
Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.;Cancer Research Institute, Seoul National University, Seoul, Korea.;Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
[62]
Department of Anatomical Pathology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
[63]
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
[64]
The University of Sydney, Sydney, New South Wales, Australia.
[65]
Division of Obstetrics and Gynaecology, Medical School, University of Western Australia, Crawley, Western Australia, Australia.;Department of Gynaecological Oncology, St John of God Subiaco Hospital, Subiaco, Western Australia, Australia.
[66]
School of Clinical Medicine, Faculty of Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.;Department of Surgery, Prince of Wales Private Hospital, Randwick, New South Wales, Australia.
[67]
School of Clinical Medicine, Faculty of Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.
[68]
Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
[69]
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.;Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
[70]
Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
[71]
Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.;Women's Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, Pennsylvania.;Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
[72]
Cancer Research Institute, Seoul National University, Seoul, Korea.;Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.;Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, South Korea.
[73]
Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.
[74]
British Columbia's Gynecological Cancer Research Team (OVCARE), University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, British Columbia, Canada.;Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.;Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
[75]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.;Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
[76]
The University of Sydney, Sydney, New South Wales, Australia.;Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.
[77]
The University of Sydney, Sydney, New South Wales, Australia.;Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.;Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.;The Daffodil Centre, a joint venture with Cancer Council NSW, The University of Sydney, Sydney, New South Wales, Australia.
[78]
School of Clinical Medicine, Faculty of Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.;Gynaecological Cancer Centre, Royal Hospital for Women, Sydney, New South Wales, Australia.;Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Sydney, New South Wales, Australia.
[79]
主题词
女(雌)性(Female);人类(Humans);肿瘤分期(Neoplasm Staging);卵巢肿瘤(Ovarian Neoplasms);腺癌, 黏液(Adenocarcinoma, Mucinous);预后(Prognosis);胃肠肿瘤(Gastrointestinal Neoplasms)
DOI
10.1158/1078-0432.CCR-22-1206
PMID
36222710
发布时间
2024-10-11
- 浏览0
Clinical cancer research
Clinical cancer research
5383-5395页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
